Summary: The new two-channel system for auditory and vestibular evoked potential testing offers improved flexibility, scalability, and seamless integration with its Maestro software platform.

Takeaways:

  1. Advanced Diagnostics: Celesta supports a wide range of auditory and vestibular tests, including ABR, eABR, ECochG, MLR, LLR, and VEMP, with plans to integrate HEARLab ACA for expanded capabilities.
  2. Streamlined Workflows: Seamless integration with Inventis’ Maestro software enables unified device management, enhancing efficiency and precision in clinical settings.
  3. Smart Features: Celesta simplifies setup with guided electrode connections, LED indicators, and software-based configurations, making it ideal for diverse medical environments.

Inventis, a provider in audiology and balance diagnostic solutions, announced the launch of Celesta, a next-generation two-channel system designed for comprehensive auditory and vestibular evoked potential testing. Offering flexibility and scalability, Celesta is a solution that is designed to meet the diverse needs of clinicians in a wide range of medical settings.

Integrating Celesta into Clinical Workflows

Celesta is designed to improve clinical workflows and elevate diagnostic precision through its seamless integration with Maestro, the all-in-one software platform exclusively developed by Inventis. This integration ensures unified management of all Inventis devices, delivering unparalleled efficiency and adaptability for clinicians conducting advanced testing procedures.

Auditory and Vestibular Testing

The Celesta system is designed with a highly scalable, modular approach, enabling users to configure it based on their specific needs. Whether for a small clinic or a large hospital network, Celesta offers robust features tailored to auditory and vestibular testing, including ABR, eABR, ECochG, MLR, LLR, and both cervical and ocular VEMP tests. Additionally, the system is set to include the HEARLab ACA (Aided Cortical Assessment), currently under implementation, further expanding its diagnostic capabilities.

Celesta is equipped with advanced smart features to streamline clinical workflows and enhance efficiency, speed, and ease of use. From its automatic single-channel switch and guided electrode connection with LED indicators, to software-based electrode configuration and dedicated cervical and ocular VEMP tests, Celesta simplifies setup and ensures precise, high-quality diagnostic results across various applications.

Further Reading

Stereotactic Radiosurgery Achieves High Rates of Tumor Control for Certain Vestibular Schwannomas

“Celesta marks our company’s entry into the evoked potentials segment, a key step in our growth strategy” says Massimo Martinelli, General Manager of Inventis. “Celesta fully embodies the Inventis DNA. Extreme ease of setup and use, flexibility in configuration, full integration with our Maestro software suite, smartness, accessibility: these are features shared by all the instruments in our orchestra, with the sole aim of improving patient care.”

Celesta is now available for pre-order (first deliveries at the beginning of 2025). 

Photo: Inventis